Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

195
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
195
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

218
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
218
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

115
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
115
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

152
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
152
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

528
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
528
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

159
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
159

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Characteristics and Outcomes of Patients Presenting with Acute Coronary Syndromes and Suspected Plaque Erosion Based on Clinical and Laboratory Criteria.

Journal of cardiovascular development and disease·2025
Same author

Predictors of Five-Year Outcomes in Patients with Acute Coronary Syndromes.

Journal of cardiovascular development and disease·2025
Same author

Age and Vasodilator Response to Different Hyperemic Agents: Adenosine versus Contrast Medium.

Reviews in cardiovascular medicine·2024
Same author

A Novel Hemodynamic Index Characterizing Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair: The MPF.

JACC. Advances·2024
Same author

PCI Deferral Based on Fractional Flow Reserve or Optical Coherence Tomography: Two-Year Results of the Forza Trial.

Reviews in cardiovascular medicine·2024
Same author

Management of vulnerable patient phenotypes and acute coronary syndrome mechanisms.

International journal of cardiology·2024

Related Experiment Video

Updated: Dec 20, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

2019 novel Coronavirus: current knowledge, cardiovascular implications and management.

Luigi Cappannoli1, Roberto Scacciavillani2, Giulia Iannaccone2

  • 1Department of Cardiovascular and Thoracic Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy - luigi.cappannoli@gmail.com.

Minerva Cardiology and Angiology
|May 31, 2020
PubMed
Summary

This review details the novel coronavirus (SARS-CoV-2) and its high contagion rate, distinguishing it from prior viruses. It also examines the significant cardiovascular implications of COVID-19, including direct myocardial injury and ACE2 enzyme interactions.

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

Related Experiment Videos

Last Updated: Dec 20, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

Area of Science:

  • Virology
  • Infectious Diseases
  • Cardiology

Background:

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in late 2019, rapidly leading to a global pandemic.
  • Understanding SARS-CoV-2's unique characteristics and high transmissibility is crucial for effective public health responses.
  • Previous highly pathogenic coronaviruses caused significant outbreaks, necessitating comparative analysis.

Purpose of the Study:

  • To differentiate SARS-CoV-2 from previous highly pathogenic coronaviruses.
  • To elucidate the clinical presentation and diagnostic strategies for SARS-CoV-2 infection.
  • To review the cardiovascular implications of COVID-19, including direct myocardial injury and related pathophysiology.

Main Methods:

  • Literature review focusing on SARS-CoV-2 characteristics, clinical presentation, diagnosis, and cardiovascular effects.
  • Analysis of the virus's interaction with the Angiotensin-Converting Enzyme 2 (ACE2) pathway.
  • Examination of current clinical management strategies, including intensive care and therapeutic interventions.

Main Results:

  • SARS-CoV-2 exhibits distinct features contributing to its high contagiousness.
  • COVID-19 presents with diverse clinical manifestations, requiring accurate diagnosis for management.
  • The virus can directly impact the cardiovascular system, leading to myocardial injury and other cardiac complications.

Conclusions:

  • Effective management of SARS-CoV-2 infection relies on understanding its unique virology, clinical presentation, and diagnostic criteria.
  • Cardiovascular involvement is a significant concern in COVID-19, with implications for patient outcomes.
  • Further research into SARS-CoV-2 pathophysiology and therapeutic strategies, including those targeting the ACE2 pathway, is warranted.